Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/30004| Title: | Influence of L-arginine during bovine in vitro fertilization |
| Authors: | Guimarães Silva, Thiago Velasco da Silva, Bruno Baraúna de Sá, André Luiz Alves da Costa, Nathalia Nogueira Sampaio, Rafael Vilar Cordeiro, Marcela da Silva Santana, Priscila Di Paula Bessa Adona, Paulo Roberto Santos, Simone do Socorro Damasceno Miranda, Moysés dos Santos Ohashi, Otávio Mitio |
| Keywords: | Blastocysts;Bos indicus;Bos taurus;Cleavage;Embryo;IVF;Oocytes;Semen;Sperm capacitation;Spermatozoa |
| Issue Date: | Dec-2014 |
| Publisher: | NISCAIR-CSIR, India |
| Abstract: | The objective of this work was to evaluate the effect of using L-arginine during in vitro fertilization (IVF) on in vitro embryonic development using Bos taurus and Bos indicus semen. Effect of different concentrations (0, 1, 10 and 50 mM) of L-arginine, added to the IVF medium, was evaluated on the fertilization rate at 18 h post-fertilization (hpf), NO3-/NO2- production during IVF by the Griess colorimetric method (30 hpf), cleavage and blastocyst rates (on Day 2 and Day 7 of culture, respectively) and total blastocyst cell number (Day 7 of culture). The results reveal that the addition of 50 mM L-arginine to IVF medium, with either Bos taurus or Bos indicus spermatozoa, decreased the cleavage rate and blastocyst rate compared to the control group. Other concentrations did not affect embryo production. However, 1 mM L-arginine with Bos indicus semen increased the proportion of hatched blastocysts. These results indicate that high L-arginine concentrations may exhibit toxic effects on bovine gametes during in vitro fertilization. |
| Page(s): | 1159-1164 |
| ISSN: | 0975-1009 (Online); 0019-5189 (Print) |
| Appears in Collections: | IJEB Vol.52(12) [December 2014] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB 52(12) 1159-1164.pdf | 113.46 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.